Slideshow

In Case You Missed It: Psychiatric Times Psychedelics Supplement

Author(s):

Psychiatric Times Editors

Vol. 39, Issue 9 covers the latest in psychedelics research and development in psychiatry.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!
Related Videos
ketamine
Tasphong/AdobeStock
Andrii Yalaanskyi/AdobeStock
Jorm Sangsorn/AdobeStock
RolfImages/AdobeStock
CravenA/AdobeStock
brain
Related Content
psilocybin
June 23rd 2025

COMP360 Psilocybin for Treatment-Resistant Depression: Positive Phase 3 Efficacy Data

Leah Kuntz
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
clinical trial
April 21st 2025

MindMed Begins Phase 3 Emerge Study of MM120 in Patients With Major Depressive Disorder

Grace Koennecke
David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders
April 6th 2021

David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders

Angela A. Coombs, MD Jennifer Sotsky, MD, MS
Psychiatric Times Through the Years: The Last 5 Years in February Covers
February 22nd 2025

Psychiatric Times Through the Years: The Last 5 Years in February Covers

Megan McSweeney
Ronstik/AdobeStock
February 14th 2025

Week in Review: February 10-14

Megan McSweeney
© 2025 MJH Life Sciences

All rights reserved.